Hawaii Cannabis
Market Intelligence Report

Hawaii's regulated medical cannabis system generates approximately $5.3 million per month, or roughly $64 million annually, through 8 licensed dispensary companies operating about 24-25 retail locations across Oahu, Maui, Hawaii Island, and Kauai. The system captures an estimated 86%-87% of all spending by its 28,735 active registered patients (year-end 2025) — a notably high capture rate validated when researchers found survey-based spending estimates matched actual BioTrack point-of-sale data at a 98.6% accuracy rate.

A 66-page report commissioned by the Hawaii Department of Health and prepared by Cannabis Public Policy Consulting, released in December 2025, found that Hawaii's true cannabis economy extends well beyond the regulated medical system: medical sales combined with hemp-derived cannabinoid sales are worth an estimated $16.5 million to $32 million per month, with non-patient adult hemp spending alone estimated at $6.17 million per month. The same report projects the total legal market could reach $59 million to $95 million per month within five years of adult-use legalization — and a concrete step toward that outcome is already underway: companion bills HB 1624 and SB 2420, introduced January 21, 2026, would place an adult-use legalization question before voters on the November 2026 ballot.

Hawaii's population of roughly 1.45 million has one of the highest median household incomes in the country, alongside a substantial visitor population whose cannabis spending the state's own research now quantifies separately from resident demand. (Official, Census ACS 2024)

Hawaii's medical cannabis program is regulated by the Department of Health's Office of Medical Cannabis Control and Regulation. The state licenses exactly 8 dispensary companies, two per county (Honolulu, Maui, Hawaii, and Kauai), operating roughly 24-25 total retail locations. Annual license fees can exceed $100,000 regardless of sales volume, and mandatory annual financial audits add further compliance burden, particularly for smaller operators — a cost structure the state's own December 2025 report flagged as a barrier to diverse participation in any future legalized market.

Hawaii does not currently operate a dedicated cannabis tax-incentive or grant program; the state's December 2025 report instead recommends future licensing fee structures be made more affordable to encourage diverse, including legacy-farmer, participation if adult-use legalization proceeds.

Hawaii's regulated supply chain runs through 8 licensed, vertically structured dispensary companies. The state's December 2025 report modeled the cultivation capacity an adult-use system would require: roughly 117,500 harvested plants annually, translating to between 17 and 67 indoor cultivation facilities, or 47 to 376 outdoor facilities, depending on canopy rules. The report stressed that strong production management would be necessary to prevent oversupply, price collapse, and diversion to illicit markets if the program expands. Separately, home cultivation already produces an estimated 3,500 to 46,000 pounds of cannabis at any given time across medical patients and adult consumers. (Modeled-Estimated, CPPC/DOH study.)

Medical patients spend an estimated $210 per month on cannabis across all sources, and the regulated dispensary system captures 86%-87% of that spending. Supply reliability is generally strong — 68% of patients reported "plenty of supply" and fewer than 5% reported serious shortages — though patients on Molokai and Lanai face 70-90 minute travel times to reach the nearest dispensary. (Modeled-Estimated, CPPC/DOH study.)

Hawaii's 8 dispensary companies operate two licenses each across the state's four counties: Honolulu, Maui, Hawaii, and Kauai. The state's December 2025 report's projected post-legalization retail footprint (65 outlets) would be distributed 33 on Oahu, 13 on Hawaii Island, 12 on Maui, 5 on Kauai, and one each on Molokai and Lanai — a useful proxy for relative county-level demand even though it reflects a future, not current, scenario. (Modeled-Estimated.)

Hawaii's current $100,000+ annual license fee, applied regardless of sales volume, is a defining cost-to-operate feature for its 8 existing dispensary companies.

Vendor demand signal tracks which product and service categories Hawaii's 8 licensed dispensary companies are actively sourcing this quarter.

Hawaii's medical program is funded primarily through licensing fees rather than a dedicated point-of-sale excise tax; annual dispensary license fees exceed $100,000 regardless of sales volume. The state's December 2025 tax modeling found a 15% effective tax rate would maximize future adult-use tax revenue while keeping the largest share of consumers in the legal market, compared to a 10% rate (better illicit-market deterrence, lower revenue) or 20% rate (higher revenue, greater risk of pushing buyers to illicit sellers). No dedicated cannabis sales/excise tax currently exists since adult-use sales are not yet legal. (Modeled-Estimated for the tax-rate analysis; Not Available for any current excise tax, since none exists.)

Hawaii is the only state in this report set with no land-bordering states. Its cannabis market dynamics are instead shaped by tourism flows from its primary visitor source markets, which the state's own December 2025 report quantified directly: tourists are projected to add at least $11.5 million per month in cannabis spending under an adult-use system, with domestic (mainland U.S.) visitors as the primary driver.

Hawaii does not publish a consolidated statewide cannabis-industry employment figure for its 8 licensed dispensary companies. The state's December 2025 report's adult-use cultivation modeling (117,500 plants/year, requiring 17-376 facilities depending on structure) implies meaningful future job creation if legalization proceeds, but no official current employment total exists. (Not Available.)

Hawaii's medical program does not include a dedicated social equity license track. The state's December 2025 report explicitly recommends that any future adult-use licensing structure keep entry costs affordable, noting that legacy farmers surveyed showed very low willingness to pay high license fees — a direct equity-relevant policy recommendation for future legislation, not yet enacted. (Official recommendation; not yet enacted into law.)

Hawaii's own state-commissioned research provides an unusually direct illicit/unregulated market estimate: non-patient adult consumers primarily source cannabis from illicit sellers, friends and family, homegrow, and hemp retailers, with hemp products alone accounting for an estimated $6.17 million per month in non-patient spending (nearly 31% of that group's combined hemp-and-cannabis spending). Home cultivation is estimated at 3,500 to 46,000 pounds of cannabis at any given time across all users. (Modeled-Estimated, CPPC/DOH study.)

This report blends official Hawaii DOH licensing and BioTrack sales data, the December 2025 state-commissioned CPPC market study (clearly labeled wherever its modeled/projected figures are used), legislative bill filings, and federal demographic sources.

This report compiles data from the Hawaii Department of Health, the December 2025 Cannabis Public Policy Consulting market study commissioned by the state, the Hawaii Legislature, federal demographic sources, and reputable cannabis policy media.